FDA Public Workshop March 9-10: E-Cigarettes and the Public Health

FDA The FDA will hold a public workshop on March 9-10 focusing on the effects of e-cigarettes on individual health. Topics will include:

Topography (patterns of use including number of puffs per session, puff volume, puff duration, and velocity);
Exposures and toxicological considerations;
Pharmacokinetics and pharmacodynamics of nicotine exposure in users;
Abuse liability and dependence;
Short and long-term health effects in users;
Considerations for high risk or vulnerable populations; and
Human factors.

This workshop is the second in a series of three focused on electronic cigarettes and the public health, intended to better inform the FDA about these products. The information gathered at these workshops will not inform the FDA’s pending deeming regulation for additional tobacco products, as the open comment period regarding the proposed rule ended August 8, 2014. However, it may inform other or additional regulations, as well as assist them in carrying out the law if it moves forward,

The first workshop in this series, held in December 2014, focused on product science, protective packaging, labeling, and the environmental impact of e-cigarettes. The third (date TBA) will focus on the impact of e-cigarettes on the population, including discussions of product appeal (e.g., impact of advertising, marketing, flavorings, consumer perceptions), impact on nonusers (second and third-hand exposures), and product labeling.

Webcasts will also be available. Find full information here.

You can also request to speak during the public comment session. Deadline: February 20th.